Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Outlook Therapeutics, Inc. | tv484221_ex31-2.htm |
| 10-K/A - FORM 10-K/A - Outlook Therapeutics, Inc. | tv484221_10ka.htm |
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO
SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Pankaj Mohan, certify that:
| 1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Oncobiologics, Inc. (the “registrant”); and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: January 29, 2018
| /s/ Pankaj Mohan | |
| Pankaj Mohan, Ph.D. | |
| President and Chief Executive Officer |